ArticleDiabetes, obesity & metabolism2026

Cost-Effectiveness of Pharmacologic Therapies for Metabolic Dysfunction-Associated Steatohepatitis With Significant Fibrosis in the United States.

Ali A Abdeen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.